🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
Single arm, single site, open-label Phase II study of the effects of oral o...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2019-06-03
Trial ID
NCT03786796
Treatments Being Tested
This phase 1b trial is designed to evaluate the safety and tolerability of ...
Status
Not Yet Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2025-11-01
Trial ID
NCT07090369
Treatments Being Tested
The goal of this phase 2 clinical trial is to learn if the three treatments...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06650709
Treatments Being Tested
This is a randomized, international, multicenter, Phase II study designed t...
Status
Completed
Location
Duke University
Start Date
2018-10-04
Trial ID
NCT03167619
Treatments Being Tested
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
The objective of this study was to assess the efficacy and safety of the co...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2021-07-22
Trial ID
NCT04729387
Treatments Being Tested
This randomized phase II/III trial studies how well cediranib maleate and o...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-05-03
Trial ID
NCT02502266
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested